Free Webinar: Italfarmaco Givinostat Development Program Update
The webinar will review the Italfarmaco Givinostat development program for Duchenne and Becker Muscular Dystrophy. Content that will be covered, includes:
Updates from the EPIDYS Study, a phase 3 clinical trial of Givinostat in ambulatory boys with DMD.
Data from Italfarmaco’s long term studies of Givinostat in DMD populations.
30 minute Q & A.
Paolo Bettica, MD, PhD Vice President of Research and Development, Italfarmaco S.p.A
Michael Kelly, Chief Scientific Advisor, CureDuchenne
Ana Christensen, Patient Science Liaison, TRINDS
Click here to watch the recording of the webinar. You’ll be prompted to enter your name and email address to view the recording.